Yodai Kobayashi

Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer’s disease

Yodai Kobayashi, Hirosuke Sugahara, Kousuke Shimada et al. · Scientific Reports · 2017 · 387 citations · Full text

Therapeutic Potential, Dysbiosis, Neurochemical Biomarkers +21

Effects of Bifidobacterium breve A1 on the cognitive function of older adults with memory complaints: a randomised, double-blind, placebo-controlled trial

Yodai Kobayashi, Tetsuya Kuhara, Mamoru Oki et al. · Beneficial Microbes · 2019 · 178 citations

Identification of Faecalibacterium prausnitzii strains for gut microbiome-based intervention in Alzheimer’s-type dementia

Atsushi Ueda, Shoji Shinkai, Hirotsugu Shiroma et al. · Cell Reports Medicine · 2021 · 134 citations · Full text

Bifidobacterium Breve A1 Supplementation Improved Cognitive Decline in Older Adults with Mild Cognitive Impairment: An Open-Label, Single-Arm Study

Yodai Kobayashi, Tomoyasu Kinoshita, Alvin M. Matsumoto et al. · The Journal of Prevention of Alzheimer s Disease · 2019 · 111 citations · Full text

Single-arm Study, Alzheimer's Disease, Aging +9

Effect of combined bifidobacteria supplementation and resistance training on cognitive function, body composition and bowel habits of healthy elderly subjects

Takuya Inoue, Yodai Kobayashi, Naoko Mori et al. · Beneficial Microbes · 2018 · 109 citations · Full text